Second, we studied the effects of the chronic administration of DBT and thiamine in two mouse models: a FUS (Thy-1.FUS 1–359) transgenic mouse model of amyotrophic lateral sclerosis (ALS) and a model of ultrasound-induced stress. Here, THY1 is linked to amyotrophic lateral sclerosis.